Highlights and Quick Summary
- Common Equity (Total) for the quarter ending December 31, 2022 was $8.99 Million (a -38.45% decrease compared to previous quarter)
- Year-over-year quarterly Common Equity (Total) increased by 19.6%
- Annual Common Equity (Total) for 2022 was $2.88 Million (a 0.0% decrease from previous year)
- Annual Common Equity (Total) for 2022 was $2.88 Million (a -85.6% decrease from previous year)
- Annual Common Equity (Total) for 2021 was $20 Million (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Equity (Total) of Benitec Biopharma Limited
Most recent Common Equity (Total)of BNTC including historical data for past 10 years.Interactive Chart of Common Equity (Total) of Benitec Biopharma Limited
Benitec Biopharma Limited Common Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $8.99 | $14.61 | $2.88 | $7.52 | $2.88 |
| 2021 | $10.84 | $15.48 | $20.01 | $10.93 | $20.01 |
| 2020 | $14.63 | $7.74 | $10.24 | $12.34 | $10.24 |
| 2019 | – | – | – | $14.87 | $16.59 |
| 2018 | – | – | – | – | $14.53 |
| 2017 | – | – | – | $14.83 | $16.21 |
| 2016 | – | $14.96 | $13.72 | $17.94 | $13.72 |
| 2015 | – | – | $19.65 | $19.99 | $19.99 |
| 2014 | – | – | $25.35 | $30.8 | $30.8 |
| 2013 | $0.65 | – | – | – | $0.66 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology